## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -1.7% below STRENGTH zone (3.0-6.0%); PEG 3.95 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($58.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Schroder Investment Management Group Sells 183,490 Shares of Rollins, Inc. $ROL**
- Source: MarketBeat | 20251202T114723 | Bullish | Relevance: 99%
- Schroder Investment Management Group reduced its stake in Rollins, Inc. (NYSE:ROL) by 18.8%, selling 183,490 shares. Despite this trim, other major institutional investors like Norges Bank, AMF Tjanstepension AB, and Westfield Capital Management Co. LP significantly increased their holdings. Rollins recently reported strong earnings, exceeding analyst expectations with 12% revenue growth, and increased its quarterly dividend.

**2. Franklin Resources Inc. Acquires 38,143 Shares of Rollins, Inc. $ROL**
- Source: MarketBeat | 20251130T091700 | Bullish | Relevance: 99%
- Franklin Resources Inc. significantly increased its stake in Rollins, Inc. by acquiring an additional 38,143 shares, bringing its total holdings to 277,126 shares valued at $15.64 million. This article details other institutional investments, insider trading activity, and recent analyst ratings for Rollins, which maintains a "Moderate Buy" consensus and an average price target of $63.42. Rollins also announced a dividend increase and reported strong quarterly earnings, beating EPS estimates and achieving 12% year-over-year revenue growth.

**3. Rollins (NYSE: ROL) sets Dec. 9, 2025 NYSE sell-side analyst event webcast details**
- Source: Stock Titan | 20251201T161800 | Neutral | Relevance: 98%
- Rollins (NYSE: ROL) announced it will host a 2025 Sell-Side Analyst Conference at the New York Stock Exchange on Tuesday, December 9, 2025, at 9:00 a.m. ET. CEO Jerry Gahlhoff and CFO Ken Krause, along with other leaders, will discuss strategic initiatives and future value creation. The event will be webcast live, and a replay will be available for 180 days.

**4. Mackenzie Financial Corp Increases Position in Rollins, Inc. $ROL**
- Source: MarketBeat | 20251202T115150 | Bullish | Relevance: 98%
- Mackenzie Financial Corp increased its stake in Rollins, Inc. (NYSE: ROL) by 10.8%, bringing its total holdings to 954,142 shares valued at $53.8 million. This increase contributes to institutional investors owning approximately 51.8% of the company. Rollins recently reported strong quarterly earnings, beating analyst expectations with $0.35 EPS and $1.03 billion in revenue, and subsequently boosted its quarterly dividend.

**5. Prudential Financial Inc. Acquires 15,699 Shares of Rollins, Inc. $ROL**
- Source: MarketBeat | 20251130T110522 | Bullish | Relevance: 98%
- Prudential Financial Inc. significantly increased its stake in Rollins, Inc. (NYSE:ROL) by 11% in Q2, acquiring an additional 15,699 shares for a total holding valued at $8,958,000. This increase comes as Rollins demonstrates strong financial performance, beating EPS expectations, achieving 12% revenue growth, and raising its quarterly dividend. Analysts maintain a "Moderate Buy" rating for the stock, with an average target price of $63.42.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Barclays | $72 | $60 | +20% |
| 2025-11-12 | Bernstein | $70 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Barclays | up | Overweight |
| 2025-11-12 | Bernstein | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($3295.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Heavy insider selling: $3296M sold (6 transactions in 90 days).
2. Valuation stretched: PEG 3.9x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.95 signals overvaluation risk, limited margin of safety. Forward P/E 47.6x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Analyst sentiment positive (1 raises, avg +20%). Insider selling cluster ($3295.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.3B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 3.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.95 |
| Forward P/E | 47.6 |
| Current P/E | 53.3 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.1% to -1.7% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.7pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.66% (CS: 42) | Neutral |
| RSI_14 | 63.1 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.023x | Above |
| vs SMA50 | 1.050x | Above |
| vs SMA200 | 1.085x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $60.90
- **Stop Loss:** $58.82 (3.4% risk)
- **Target:** $62.98 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 480
- **Position Value:** $29,232.00
- **Portfolio %:** 29.23%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*